Cargando…

Longitudinal change of FEV(1) and inspiratory capacity: clinical implication and relevance to exacerbation risk in patients with COPD

BACKGROUND AND OBJECTIVE: FEV(1) is the gold standard for assessment of COPD. We compared efficacy of FEV(1), inspiratory capacity (IC), and IC to total lung capacity (TLC) ratio in the evaluation of COPD and their association with exacerbation. METHODS: We analyzed the association of dyspnea severi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jo, Yong Suk, Kim, Sung Kyoung, Park, Seoung Ju, Um, Soo-Jung, Park, Yong-Bum, Jung, Ki Suck, Kim, Deog Kyeom, Yoo, Kwang Ha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366360/ https://www.ncbi.nlm.nih.gov/pubmed/30787605 http://dx.doi.org/10.2147/COPD.S189384

Ejemplares similares

Cut-off value of FEV(1)/FEV(6) to determine airflow limitation using handheld spirometry in subjects with risk of chronic obstructive pulmonary disease
por: Hwang, Yong Il, et al.
Publicado: (2021)

Air Trapping and the Risk of COPD Exacerbation: Analysis From Prospective KOCOSS Cohort
por: Kim, Youlim, et al.
Publicado: (2022)

Comparison of Korean COPD Guideline and GOLD Initiative Report in Term of Acute Exacerbation: A Validation Study for Korean COPD Guideline
por: Hwang, Yong Il, et al.
Publicado: (2014)

Rapid FEV(1)/FVC Decline Is Related With Incidence of Obstructive Lung Disease and Mortality in General Population
por: Choi, Kwang Yong, et al.
Publicado: (2022)

Comparison of COPD Assessment Test and Clinical COPD Questionnaire to predict the risk of exacerbation
por: Jo, Yong Suk, et al.
Publicado: (2017)

Clinical relevance of maximal inspiratory pressure: determination in COPD exacerbation
por: Tudorache, Voicu, et al.
Publicado: (2010)

FVC, but not FEV(1,) is associated with clinical outcomes of asthma-COPD overlap
por: An, Tai Joon, et al.
Publicado: (2022)

Clinical impacts of the classification by 2017 GOLD guideline comparing previous ones on outcomes of COPD in real-world cohorts
por: Song, Jin Hwa, et al.
Publicado: (2018)

Prediction of severe exacerbations and mortality in COPD: the role of exacerbation history and inspiratory capacity/total lung capacity ratio
por: Cardoso, João, et al.
Publicado: (2018)

Different impacts of respiratory symptoms and comorbidities on COPD-specific health-related quality of life by COPD severity
por: Lee, Hyun, et al.
Publicado: (2017)

Effect of low protein intake on acute exacerbations in mild to moderate chronic obstructive pulmonary disease: data from the 2007–2012 KNHANES
por: Park, Sojung, et al.
Publicado: (2021)

Association of body mass index and COPD exacerbation among patients with chronic bronchitis
por: Shin, Sun Hye, et al.
Publicado: (2022)

Lack of Association between Inhaled Corticosteroid Use and the Risk of Future Exacerbation in Patients with GOLD Group A Chronic Obstructive Pulmonary Disease
por: Shin, Sun Hye, et al.
Publicado: (2022)

Association of the Neutrophil-to-Lymphocyte Ratio with Lung Function and Exacerbations in Patients with Chronic Obstructive Pulmonary Disease
por: Lee, Heock, et al.
Publicado: (2016)

A pilot study of inspiratory capacity and resting dyspnea correlations in exacerbations of COPD and asthma
por: Pretto, Jeffrey J, et al.
Publicado: (2007)

Clinical implications of blood eosinophil count in patients with non-asthma–COPD overlap syndrome COPD
por: Song, Jin Hwa, et al.
Publicado: (2017)

Prevalence, characteristics, and risk of exacerbation in young patients with chronic obstructive pulmonary disease
por: Jo, Yong Suk, et al.
Publicado: (2022)

Factors associated with exacerbation in mild- to-moderate COPD patients
por: Kim, Joo Kyung, et al.
Publicado: (2016)

Cut-off value of FEV(1)/FEV(6) as a surrogate for FEV(1)/FVC for detecting airway obstruction in a Korean population
por: Chung, Kyung Soo, et al.
Publicado: (2016)

Korean Asthma Guideline 2014: Summary of Major Updates to the Korean Asthma Guideline 2014
por: Kim, Deog Kyeom, et al.
Publicado: (2016)

The Association Between Eosinophil Variability Patterns and the Efficacy of Inhaled Corticosteroids in Stable COPD Patients
por: Yoon, Jung-Ki, et al.
Publicado: (2020)

Longitudinal FEV(1) and Exacerbation Risk in COPD: Quantifying the Association Using Joint Modelling
por: Zhudenkov, Kirill, et al.
Publicado: (2021)

Inspiratory muscle strength and walking capacity in patients with COPD
por: Kofod, Linette Marie, et al.
Publicado: (2019)

Peak-Inspiratory-Flow-Rate Guided Inhalation Therapy Reduce Severe Exacerbation of COPD
por: Chen, Shih-Yu, et al.
Publicado: (2021)

Benefits of short inspiratory muscle training on exercise capacity, dyspnea, and inspiratory fraction in COPD patients
por: Shahin, Barakat, et al.
Publicado: (2008)

Characteristics of Patients with Chronic Obstructive Pulmonary Disease at the First Visit to a Pulmonary Medical Center in Korea: The KOrea COpd Subgroup Study Team Cohort
por: Lee, Jung Yeon, et al.
Publicado: (2016)

What Can We Apply to Manage Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Acute Respiratory Failure?
por: Kim, Deog Kyeom, et al.
Publicado: (2018)

Bronchodilator Response of FEV6 and FEV3 as Surrogates of Forced Vital Capacity
por: Mehrparvar, Amir Houshang, et al.
Publicado: (2014)

Natural course of early COPD
por: Rhee, Chin Kook, et al.
Publicado: (2017)

Effects of Vitamin D Intake on FEV1 and COPD Exacerbation: A Randomized Clinical Trial Study
por: Zendedel, Abolfazl, et al.
Publicado: (2015)

Joint longitudinal model-based meta-analysis of FEV(1) and exacerbation rate in randomized COPD trials
por: Llanos-Paez, Carolina, et al.
Publicado: (2023)

COPD exacerbations and patient-reported outcomes according to post-bronchodilator FEV(1) – a post-hoc analysis of pooled data
por: Chai, Chee-Shee, et al.
Publicado: (2023)

Usefulness of inspiratory capacity measurement in COPD patients in the primary care setting
por: Madueño, Antonio, et al.
Publicado: (2009)

Effects of combined tiotropium/olodaterol on inspiratory capacity and exercise endurance in COPD
por: O'Donnell, Denis E., et al.
Publicado: (2017)

Radiographic Phenotypes Affect the Risk of Inhaled Corticosteroid-Associated Pneumonia in Patients with COPD
por: Lee, Hyo Jin, et al.
Publicado: (2022)

Male current smokers have low awareness and optimistic bias about COPD: field survey results about COPD in Korea
por: Hwang, Yong Il, et al.
Publicado: (2019)

Prognostic marker for severe acute exacerbation of chronic obstructive pulmonary disease: analysis of diffusing capacity of the lung for carbon monoxide (D(LCO)) and forced expiratory volume in one second (FEV(1))
por: Choi, Juwhan, et al.
Publicado: (2021)

Variability of FEV(1) and Criterion for Acute Pulmonary Exacerbation
por: Jenkins, Bradlee A., et al.
Publicado: (2014)

Clinical Characteristics of Chronic Obstructive Pulmonary Disease in Female Patients: Findings from a KOCOSS Cohort
por: Choi, Joon Young, et al.
Publicado: (2020)

Development of a daily predictive model for the exacerbation of chronic obstructive pulmonary disease
por: Jo, Yong Suk, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_e7144u3jeli1fn73po43i2ls8e